Showing results 1 to 20 of 29
next >
| Issue Date | Title | Author(s) |
| 9-Apr-2018 | A comprehensive pan-cancer molecular study of gynecologic and breast cancers | Berger, AC; Korkut, A; Kanchi, RS; Hegde, AM; Lenoir, W, et al |
| 5-Apr-2018 | A pan-cancer analysis of enhancer expression in nearly 9000 patient samples | Chen, H; Li, C; Peng, X; Zhou, Z; Weinstein, JN, et al |
| 24-Oct-2018 | A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily | Korkut, A; Zaidi, S; Kanchi, RS; Rao, S; Gough, NR, et al |
| 5-Apr-2018 | An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics | Liu, J; Lichtenberg, T; Hoadley, KA; Poisson, LM; Lazar, AJ, et al |
| 5-Apr-2018 | Cell-of-Origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer | Hoadley, KA; Yau, C; Hinoue, T; Wolf, DM; Lazar, AJ, et al |
| 9-Apr-2018 | Comparative molecular analysis of gastrointestinal adenocarcinomas | Liu, Y; Sethi, NS; Hinoue, T; Schneider, BG; Cherniack, AD, et al |
| 13-Aug-2018 | Comprehensive analysis of alternative splicing across tumors from 8,705 patients | Kahles, A; Lehmann, K-V; Toussaint, NC; Huser, M; Stark, SG, et al |
| 30-Oct-2018 | Comprehensive molecular characterization of the Hippo signaling pathway in cancer | Wang, Y; Xu, X; Maglic, D; Dill, MT; Mojumdar, K, et al |
| 3-Apr-2018 | Driver fusions and their implications in the development and treatment of human cancers | Gao, Q; Liang, W-W; Foltz, SM; Mutharasu, G; Jayasinghe, RG, et al |
| 9-Apr-2018 | Genomic and functional approaches to understanding cancer aneuploidy | Taylor, AM; Shih, J; Ha, G; Gao, GF; Zhang, X, et al |
| 3-Apr-2018 | Genomic and molecular landscape of dna damage repair deficiency across the cancer genome atlas | Knijnenburg, TA; Wang, L; Zimmermann, MT; Chambwe, N; Gao, GF, et al |
| 3-Apr-2018 | Genomic, pathway network, and immunologic features distinguishing squamous carcinomas | Campbell, JD; Yau, C; Bowlby, R; Liu, Y; Brennan, K, et al |
| 3-Apr-2018 | Integrated genomic analysis of the ubiquitin pathway across cancer types | Ge, Z; Leighton, JS; Wang, Y; Peng, X; Chen, Z, et al |
| 9-Apr-2018 | lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer | Wang, Z; Yang, B; Zhang, M; Guo, W; Wu, Z, et al |
| 3-Apr-2018 | Machine learning detects pan-cancer ras pathway activation in the cancer genome atlas | Way, GP; Sanchez-Vega, F; La, K; Armenia, J; Chatila, WK, et al |
| 5-Apr-2018 | Machine learning identifies stemness features associated with oncogenic dedifferentiation | Malta, TM; Sokolov, A; Gentles, AJ; Burzykowski, T; Poisson, L, et al |
| 3-Apr-2018 | Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers | Peng, X; Chen, Z; Farshidfar, F; Xu, X; Lorenzi, PL, et al |
| 5-Apr-2018 | Oncogenic signaling pathways in the cancer genome atlas | Sanchez-Vega, F; Mina, M; Armenia, J; Chatila, WK; Luna, A, et al |
| 28-Mar-2018 | Pan-cancer alterations of the myc oncogene and its proximal network across the cancer genome atlas | Schaub, FX; Dhankani, V; Berger, AC; Trivedi, M; Richardson, AB, et al |
| 3-Apr-2018 | Pan-cancer analysis of lncRNA regulation supports their targeting of cancer genes ineach tumor context | Chiu, H-S; Somvanshi, S; Patel, E; Chen, T-W; Singh, VP, et al |